Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Halozyme Licensing Deal Could Be Worth Much More Than $40M

San Diego’s Halozyme Therapeutics will receive a $40 million upfront payment, and potentially much more, as part of a collaboration and licensing deal with Alexion Pharmaceuticals.

Metacrine Gets $22 Million in Funding Round, New Board Member

San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.

Executive Q&A Rakesh Patel, Neighborhood Healthcare

In 2002, Rakesh Patel started as a family physician at Neighborhood Healthcare, an organization he now leads.

Tease photo

In Budget Move, Scripps Health to Cut Corporate Services By $30M

HEALTH: It Will Also Restructure Top Hospital Leadership

Scripps Health will cut corporate services by $30 million and replace the chief executive role at its hospitals with a new leadership model, according to media reports.

Tease photo

Becoming Part of The (Health) Plan

Wellness Cos. Help Care and Coverage Providers Find Ways to Effectively Reach and Influence Diverse Customer Bases

Swaying rural teens in Arkansas to stay away from chewing tobacco, a habit ingrained in the local culture, is no easy task. Nor is crafting relatable messages for teens on the dangers of prescription painkiller abuse.

Tease photo

Metacrine Gets $22M in Funding Round, New Board Member

San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.

Proton Therapy Center Relaunches with New Ownership

California Protons is one of only two proton therapy centers in California and 25 nationwide.

Three S.D. Scientists Receive Breakthrough Prize

Three high-profile scientists took home the prize billed as the Oscars of Science.

NanoCellect Raises $10M in Funding Round

San Diego biotech raised $10 million in a Series B round, led by investment from Illumina Ventures.

Tease photo

Section 32 Adds A Key Player to its Roster

The venture capital firm in San Diego that was launched earlier this year by former Google Ventures CEO Bill Maris has added a big name in health care.

Adamis Applying for Approval of Product that Treats Opioid Overdose

the pharmaceuticals company has submitted an application to the U.S. Food and Drug Administration seeking to begin human testing of a drug and product combo for treating opioid overdoses.

Investors Win Class-Action Status in SeaWorld Lawsuit

Investors who sued SeaWorld Entertainment for misleading on the impact of the documentary “Blackfish” have been granted class-action status.

State Attorney General Files a Lawsuit Against Bridgepoint Education

California is suing for-profit Ashford University and its parent company, San Diego-based Bridgepoint Education, alleging false promises to persuade students to enroll in the online school.

S.D. Set for a Big Role as Biotech Irras Maps Out Strategy

BIOTECH: S.D. Could Be Headquarters; Co. Lists First in Europe

What does Sweden’s stock market have to do with San Diego? Look no further than the company Irras Ab.

Tease photo

Odonate’s Planned IPO Aims for $150 Million Mark

Odonate Therapeutics has stated terms for its eye-popping $150 million initial public offering, the latest from the stealth IPO that emerged in mid-November.

CRO Navigates Tough Preclinical Testing Stage for Cos.

BIOTECH: Challenges Are Big And Small in Testing on Animals

Explora Biolabs is part of San Diego’s biotech cluster. But CEO Richard Lin likens the company to a hotel.

Tease photo

Sommetrics Adds to Board of Directors, Advisory Board

Sommetrics has added Raymond Huggenberger to its board of directors and Randall Whitfield to its advisory board.

CPUC Turns Down San Diego Gas & Electric's 2007 Wildfires Request

The CPUC denied a San Diego Gas & Electric request to bill ratepayers $379 million in damages related to the 2007 wildfires.

Economic Index: S.D. Economy Rises on National Outlook

A local index of leading economic indicators in San Diego County was up 0.6 percent in October.

NanoCellect Raises $10M in Funding Round

San Diego biotech NanoCellect Biomedical raised $10 million in a Series B round, led by investment from Illumina Ventures.

Dexcom Partners with Eli Lilly

A newly formed partnership calls for the integration of Dexcom’s continuous glucose monitoring (CGM) system with Eli Lilly and Company’s insulin delivery platform.

Synthorx Appoints Laura Shawver as CEO

Laura Shawver, who has a background as an entrepreneur and drug developer, has been tapped.

‘Genomics Evangelist’ Envisions Group Effort

Dawn Barry is a self-described genomics evangelist. But she’s not preaching to the choir.

Tease photo

New Ionis COO Named

Brett Monia, a founding member of Ionis Pharmaceuticals, has been named the company’s COO.

‘Fully Commercialized,’ Biocept Ready for Big Role

BIOTECH: Co.’s Biopsies Enable Targeted Therapy

Tissue biopsies have long been the standard in cancer care. Yet sometimes the tissue-removal procedure can’t be done for medical reasons.

Tease photo

San Diego County Got Big Boost in Life Science Jobs in 2016

FINANCE: Report Finds VC Investment Down; Average Wages Fell

Employment in the life sciences sector in San Diego County shot up nearly 19 percent year over year, according to a recent industry report for the state.

Tease photo

New Chairman Named at Salk Institute

Daniel Lewis has been named chairman of the Salk Institute’s Board of Trustees.

Illumina Revenue Jumps 18 Percent in Q3

San Diego biotech Illumina reported that its Q3 revenue climbed 18 percent year over year.

Neurocrine Biosciences Gets New CFO

Matt Abernethy has been tapped as CFO of Neurocrine Biosciences.

Ionis Licenses Second Antisense Drug

Ionis Pharmaceuticals has licensed another antisense drug to Janssen Biotech.

Odonate Therapeutics Files for $173 M IPO

San Diego-based Odonate Therapeutics has filed with the SEC to raise up to $173 million in an IPO.

Ionis Confident It Can Compete With Alnylam

PHARMA: Cos. Clash as They Target Same Illness

Tax Reform May Threaten Incentives for Orphan Drug Research

PHARMA: Sector Lobbies Against Changes; Cut Said to Bring $54B Over 10 Years

Drugmakers researching medicines for rare diseases could lose all or part of a tax credit under Republican tax overhaul proposals unveiled this month, sparking concern among San Diego’s biotech industry.

Tease photo

‘Fully Commercialized,’ Biocept Ready for Big Role

BIOTECH: Co.’s Biopsies Enable Targeted Therapy

Tissue biopsies have long been the standard in cancer care. Yet sometimes the tissue-removal procedure can’t be done for medical reasons.

Tease photo

Arcturus Completes Merger with Alcobra, Lists on Nasdaq

San Diego’s Arcturus Therapeutics is now on the public markets following a merger with Alcobra, previously based in Israel.

Palomar Health to Build New Crisis Stabilization Unit

A standalone crisis stabilization unit will be built on the Palomar Medical Center Escondido campus.

UC San Diego Forms Medical Records Partnership

UC San Diego and UC Irvine Health are now on an integrated electronic medical records platform.

Heron Wins FDA Approval for Chemotherapy Drug

The FDA has approved Heron Therapeutic's Cinvanti, an injectable drug for the prevention of chemotherapy-induced nausea and vomiting.

MaxLinear Reports Record Q3 Revenue

Carlsbad chipmaker MaxLinear Inc. reported a net loss of $9.2 million on record quarterly revenue of $113.6 million.

Heron Therapeutics Wins FDA Approval for Chemotherapy Drug

The FDA has approved Heron Therapeutic's Cinvanti, an injectable drug for the prevention of chemotherapy-induced nausea and vomiting.

Palomar Health CEO Retires

Robert Hemker has announced his retirement as president and CEO of Palomar Health.

S.D. Coordinates Efforts to Put Hospital Stay on Tourist Itinerary

ECONOMY: Campaign Touts Region’s Prowess To Drive Medical Visits

For visitors, San Diego offers much more than beaches, craft beer and convention space.

Tease photo

Ra Medical Systems Moves to a Larger Carlsbad Facility

BIOTECH: Unifying Operations Seen as Plus; Possible IPO Coming

Ra Medical Systems has outgrown its digs once again. Next month, the Carlsbad medical device company is moving to a bigger space to meet increased demand, the fifth time it has done so since forming in 2002. Its new headquarters — down the street from its current spot — will house R&D, production, sales, marketing and administrative functions in a 32,000-square-foot building.

Tease photo

Hospitals See Harm in Insurer’s Imaging Policy Change

MEDICINE: Use of Centers Expected to Cut Costs

Anthem will no longer pay for outpatient MRIs and CT scans at hospitals, a decision that at least two San Diego hospital systems fear could chip away at care — and their bottom lines.

Tease photo

Batu Biologics Gets OK to Test Cancer Immunotherapy in Humans

San Diego-based Batu Biologics has received approval from the FDA to proceed with human testing of its cancer immunotherapy.

San Diego Business Leader Takes Helm of National Trade Group

Paola Avila has been tapped as the chair of the Border Trade Alliance.

Klotho Therapeutics Raises $10 M in Funding Round

Klotho Therapeutics (KTI) raised $10 million in a Series A round from Thynk Capital, whose founder, Jim Plante, is also the founder and CEO of KTI.

AMN Healthcare Reports Solid Growth in Q3

San Diego’s AMN Healthcare, the U.S.’s largest health care and nurse staffing company, has reported year-over-year revenue growth in its third quarter.

Arcturus Therapeutics and Synthetic Genomics Announce Partnership

Two San Diego biotechs have entered into a research collaboration and licensing agreement to develop vaccines and therapeutics for both human and animal health.

Grant to Train Medi-Cal Providers Through CSU Institute for Palliative Care

A new $244,000 grant will fund palliative care education for qualified Medi-Cal providers at the California State University Institute for Palliative Care in San Marcos.

Prev